These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4126369)

  • 1. Editorial: Dengue, complement and shock.
    Ward PA
    N Engl J Med; 1973 Nov; 289(19):1034-5. PubMed ID: 4126369
    [No Abstract]   [Full Text] [Related]  

  • 2. The potential pathogenic role of complement in dengue hemorrhagic shock syndrome.
    Bokisch VA; Top FH; Russell PK; Dixon FJ; Müller-Eberhard HJ
    N Engl J Med; 1973 Nov; 289(19):996-1000. PubMed ID: 4742219
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of complement in hemorrhagic shock syndrome (dengue).
    Bokisch VA; Muller-Eberhard HJ; Dixon FJ
    Trans Assoc Am Physicians; 1973; 86():102-10. PubMed ID: 4132983
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum complement level in dengue hemorrhagic fever.
    Nishioka K
    Allerg Immunol (Leipz); 1974-1975; 20-21(4):385-92. PubMed ID: 4283486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sporadic cases of haemorrhage and-or shock during dengue epidemics.
    Sarkas JK; Chakravarty SK; Sarkar RK
    Trans R Soc Trop Med Hyg; 1972; 66(6):875-7. PubMed ID: 4653044
    [No Abstract]   [Full Text] [Related]  

  • 6. Anaphylatoxin formation by purified human C'1 esterase.
    Dias da Silva W; Lepow IH
    J Immunol; 1965 Dec; 95(6):1080-9. PubMed ID: 4158798
    [No Abstract]   [Full Text] [Related]  

  • 7. Some changes in immunity and blood in relation to clinical states of dengue hemorrhagic fever patients in Vietnam.
    Phan DT; Ha NT; Thuc LT; Diet NH; Phu LV; Ninh LY; An VT
    Haematologia (Budap); 1991; 24(1):13-21. PubMed ID: 1813358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on dengue in children at Dr. Cipto Mangunkusumo General Hospital, Jakarta (May 1973--January 1974).
    Van Peenen PF; Sinto S; Joseph PL
    Paediatr Indones; 1975; 15(5-6):143-50. PubMed ID: 1196647
    [No Abstract]   [Full Text] [Related]  

  • 9. [Inflammatory aspects and therapeutic possibilities of rheumatic diseases. Introduction].
    Ballabio CB; Fantini F
    Minerva Med; 1973 Jun; 64(46):2385-94. PubMed ID: 4124964
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of shock associated with Dengue haemorrhagic fever based on pathophysiological findings.
    Pongpanich B; Ayuthya PI; Varavithya W; Preeyasombat C; Phanichyakarn P
    Southeast Asian J Trop Med Public Health; 1975 Mar; 6(1):115-9. PubMed ID: 1145233
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on serum complement C3 and fibrin degradation products in Thai hemorrhagic fever.
    Suvatte V; Pongpipat D; Tuchinda S; Ratanawongs A; Tuchinda P; Bukkavesa S
    J Med Assoc Thai; 1973 Jan; 56(1):24-32. PubMed ID: 4685997
    [No Abstract]   [Full Text] [Related]  

  • 12. Delayed-type hypersensitivity: probable role in the pathogenesis of dengue hemorrhagic fever/dengue shock syndrome.
    Pang T
    Rev Infect Dis; 1983; 5(2):346-52. PubMed ID: 6844807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical correlates with immunopathogenesis in dengue haemorrhagic fever/dengue shock syndrome.
    Tan PS
    Malays J Pathol; 1993 Jun; 15(1):41-7. PubMed ID: 8277789
    [No Abstract]   [Full Text] [Related]  

  • 14. Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement.
    Avirutnan P; Punyadee N; Noisakran S; Komoltri C; Thiemmeca S; Auethavornanan K; Jairungsri A; Kanlaya R; Tangthawornchaikul N; Puttikhunt C; Pattanakitsakul SN; Yenchitsomanus PT; Mongkolsapaya J; Kasinrerk W; Sittisombut N; Husmann M; Blettner M; Vasanawathana S; Bhakdi S; Malasit P
    J Infect Dis; 2006 Apr; 193(8):1078-88. PubMed ID: 16544248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of dengue haemorrhagic fever/dengue shock syndrome.
    Lum LC
    Malays J Pathol; 1993 Jun; 15(1):29-33. PubMed ID: 8277786
    [No Abstract]   [Full Text] [Related]  

  • 16. T suppressor cells: role in dengue hemorrhagic fever and dengue shock syndrome.
    Pavri KM; Prasad SR
    Rev Infect Dis; 1980; 2(1):142-6. PubMed ID: 6156485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on dengue hemorrhagic fever. II. Electrolyte study.
    Varavithya W; Manu P; Kittikool J; Phongbetchara P; Kashemsant C
    J Med Assoc Thai; 1973 Jan; 56(1):15-23. PubMed ID: 4685995
    [No Abstract]   [Full Text] [Related]  

  • 18. Complement and dengue haemorrhagic fever/shock syndrome.
    Malasit P
    Southeast Asian J Trop Med Public Health; 1987 Sep; 18(3):316-20. PubMed ID: 3501613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical care aspects of dengue haemorrhagic fever/dengue shock syndrome.
    Yong BH
    Malays J Pathol; 1993 Jun; 15(1):35-9. PubMed ID: 8277788
    [No Abstract]   [Full Text] [Related]  

  • 20. [current spread of dengue hemorrhagic fever in South Asia].
    Jusatz HJ
    Med Klin; 1972 Feb; 67(5):152-6. PubMed ID: 5014139
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.